CIML, Canceropôle PACA
A therapeutic revolution is happening.
Cancéropôle PACA joins forces with Marseille-Immunopôle to the fight against cancer, through the structuration of ground-breaking platforms and the support of ambitious and strategic academic and translational research programs in the field of anti-tumoral immunotherapy.
A therapeutic revolution is happening.#research
This is the DNA of the cluster to feed local excellence, including, of course, fundamental and applied immunology, and to support the emergence of sector initiatives with strong potential.
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.
AMU, AP-HM, CIML, INNATE PHARMA
Cell- and tissue- based therapies and gene therapies hold great promise in the field of both immunotherapy and regenerative medicine.
AMU, IPC, AP-HM, Inserm
MI today is a great accomplishment as it brings together for the first time all the expertise in immunology but it is above a new strategic step for all Marseille immunology players